{"nct_id":"NCT01320085","title":"A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma","status":"COMPLETED","status_verified_date":"2024-01","start_date":"2011-03-24","start_date_type":"ACTUAL","primary_completion_date":"2014-01-07","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}